Previous 10 | Next 10 |
2024-02-16 15:25:00 ET Summary Positive 12-month interim results from the phase 3 INSPIRE study using govorestat for the treatment of patients with SORD deficiency achieved. Pre-NDA meeting with FDA to be sought out after to see if an NDA submission of govorestat for SORD deficien...
2024-02-16 12:56:48 ET More on Applied Therapeutics Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade) ARISE-HF Phase 3 Trial Likely To Disappoint Due To Multiple Red Flags Applied Therapeutics: Multiple Inflection Points Could Gene...
2024-02-16 12:29:21 ET Gainers: Pop Culture Group Co Ltd ( CPOP ) +176% . Fusion Fuel Green Ltd ( HTOO ) +127% . MicroCloud Hologram ( HOLO ) +118% . Nano X Imaging Ltd ( NNOX ) +48% . MoneyHero Ltd ( MNY ) +46% . Tarena Inte...
2024-02-16 10:08:37 ET DENVER, Colo., Feb 16, 2024 (www.247marketnews.com)- Applied Therapeutics, Inc. (NASDAQ: APLT ) reported, yesterday morning, positive interim 12-month results from the ongoing Phase 3 INSPIRE trial, in which the primary endpoints and several key secondary endpoint...
2024-02-15 17:12:12 ET Gainers: The Trade Desk ( TTD ) +20% . Applied Materials ( AMAT ) +11% . Coinbase Global ( COIN ) +11% . Backblaze ( BLZE ) +9% . Texas Roadhouse ( TXRH ) +6% . Losers: Roku ( ROKU ) -16% . ...
2024-02-15 10:00:00 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Communication Services, Info ...
2024-02-15 09:29:01 ET DENVER, Colo., Feb 15, 2024 (www.247marketnews.com) – Applied Therapeutics, Inc. (NASDAQ: APLT ) reported, this morning, achieving primary endpoints and several key secondary endpoints in its interim 12-month results from the ongoing Phase 3 INSPIRE trial, ...
2024-02-15 08:24:49 ET More on Applied Therapeutics Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade) ARISE-HF Phase 3 Trial Likely To Disappoint Due To Multiple Red Flags Applied Therapeutics: Multiple Inflection Points Could Gene...
Interim primary endpoint met; Statistically significant correlation of sorbitol with the CMT-FOM clinical outcome composite (p=0.05) Sustained, statistically significant reduction in sorbitol in govorestat-treated patients vs. placebo (p<0.001) Highly statistically significan...
2024-01-08 08:19:00 ET Summary APLT had a considerable run-up since my prior coverage. APLT remains undervalued based on just the galactosemia thesis. However, now the short-term risk has increased considerably, for numerous reasons. AT-001 failed to meet the primary endpoint...
News, Short Squeeze, Breakout and More Instantly...
Applied Therapeutics Inc. Company Name:
APLT Stock Symbol:
NASDAQ Market:
Applied Therapeutics Inc. Website:
2024-07-27 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the Company was adde...
2024-06-11 10:45:04 ET Palo Alto Networks Inc (PANW) PANW is trading UP for the last 5 days, and it at trading at $313.28 with volume of 858,188 and a one day change of $4.23 (1.37%). Palo Alto Networks Inc has a 52-week low of 201.17 and a 52-week high of $380.84. The business's 50...